Table 2.

Univariate and multivariate analysis for overall survival of glioma patients

Variable		Univariate analysis			Multivariate analysis
Age		HR	95 % CI	pvalue	HR	95 % CI	pvalue
(≥ 40 vs. < 40)		1.6	(1.4-2.0)	< 0.001	1.26	(1.04 − 1.52)	0.017
Gender
Female vs. male		0.98	(0.83–1.2)	0.79
Grade
II vs. III vs. IV		3.6	(2.2–6.2)	< 0.001	2.75	(2.06 − 3.68)	< 0.001
Recurrence
Primary vs. Recurrent vs. Secondary		2.5	(1.8–3.2)	< 0.001	2.17	(1.81 − 2.62)	< 0.001
IDH status
Wildtype vs. Mutant		3.1	(2.6–3.6)	< 0.001	2.46	(1.97–3.01)	< 0.001
Radio status
Yes vs. no		1	(0.83–1.3)	0.73
Chemo status
Yes vs. no		1.5	(1.3–1.9)	< 0.001	1.4	(1.2–1.8)	< 0.001
FCER1G
Low vs. High		0.43	(0.36–0.51)	< 0.001	0.66	(0.54 − 0.79)	< 0.001